Glenmark Pharmaceuticals board to consider Unaudited Financial Results

14 Jan 2014 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the company will be held on January 24, 2014, to consider and approve the Company Un-audited Financial Statements for the Third Quarter ended December 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2133.30 -37.20 (-1.71%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×